カテゴリ： GlobalData, フランス, 企業調査

Essilor International Compagnie Generale d’Optique SA (EI)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Essilor International Compagnie Generale d'Optique SA (EI) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7391
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：119
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：フランス
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Essilor International Compagnie Generale d’Optique SA (Essilor) designs, manufactures and distributes ophthalmic lenses, sunwear, reading glasses and optics equipment. The company offers a range of corrective lenses for correcting visual disorders such as myopia, hypermetropia and astigmatism. It also manufactures and sells non-prescription reading glasses, sunglasses, equipment, instruments and consumables used by prescription laboratories and eyecare professionals. Essilor has manufacturing facilities across North America, Latin America, Europe and Asia Middle East, Russia and Africa (AMERA). The company sells its products through a network of distributors in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Essilor is headquartered in Paris, France.

Essilor International Compagnie Generale d’Optique SA (EI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Essilor International Compagnie Generale d’Optique SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Essilor International Compagnie Generale d’Optique SA, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Essilor International Compagnie Generale d’Optique SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Essilor International Compagnie Generale d’Optique SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 11
Essilor International Compagnie Generale d’Optique SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Essilor International Compagnie Generale d’Optique SA, Medical Equipment, Deal Details 17
Partnerships 17
Fyidoctors Enters Into Licensing Agreement With Vision Source 17
Safilo Enters Into Licensing Agreement With Essilor 18
Essilor International Enters Into Licensing Agreement With High Performance Optics For Blue Light Filtering Spectacle Lens Technology 19
Coastal Contacts Enters Into Distribution Agreement With Oakley 20
Essilor International Enters Into Distribution Agreement With Lenstech Optical Lab 21
Equity Offering 22
Coastal Contacts Completes Public Offering Of Shares For US$20 Million 22
Debt Offering 24
Essilor International Raises USD328.4 Million in Public Offering of Notes Due 2017 24
Essilor International Raises USD411 Million in Public Offering of 2.375% Notes Due 2024 25
Essilor Prices Public Offering Of Bonds Due 2021 For US$687 Million 26
Essilor International Completes Private Placement Of Notes For US$300 Million 27
Acquisition 28
Essilor to Acquire Luxottica for USD58.6 Billion 28
Essilor of America Acquires Vision Source from Brazos Private Equity 30
Essilor India to Acquire 36.47% Stake in GKB Vision for USD3.6 Million 31
Essilor Acquires QC Optical 32
Essilor Acquires Majority Stake in Grand Vision 33
Essilor Acquires iCoat, Prescription Lab And Coating Specialist 34
Essilor International Completes Acquisition Of Coastal Contacts For US$387.5 Million 35
Essilor International Completes Acquisition Of Transitions Optical And Intercast Europe From PPG Industries For Up To US$1.73 Billion 37
GetLenses Acquires Vision Direct And Lensbase 39
Essilor Completes Acquisition Of Costa, Manufacturer Of Ophthalmic Lenses, For US$270 Million 40
FGX International Acquires Suntech Optics, Provider Of Eyewear 42
Essilor Acquires VIP Optical Labs 43
Essilor International Acquires Katz & Klein, Optical Lab 44
Essilor International Acquires Majority Stake In Technologies Humanware 45
Essilor International Acquires 50% Stake In Polycore Optical 46
Essilor International Acquires Majority Stake In Classic Optical Lab 47
Essilor International Acquires Majority Stake In e.magine optical 48
Essilor International Acquires Majority Stake In PSA Nilo 49
Essilor International Acquires Majority Stake In Prodigy Optical 50
Essilor Acquires Majority Stake In Onbitt 51
Essilor Acquires Majority Stake In Optiminas 52
Essilor Acquires Majority Stake In Shih Heng, Distributor Of Lens 53
Essilor Acquires Majority Stake In Spherical Optics 54
Essilor International Acquires Majority Stake In Deepak Optic 55
Essilor International Completes Acquisition Of Majority Stake In Isbir Optic 56
Essilor Acquires Majority Stake In EyeBuyDirect.com 57
Essilor International Completes Acquisition Of 51% Stake In Servi Optica 58
Essilor International Completes Acquisition Of Majority Stake In Labs SIVO 59
Essilor Completes Acquisition Of Movisia, Distributor Of Lenses 60
Essilor Acquires Majority Stake In Shanghai Tianhong Optical 61
Essilor Acquires 68.3% Stake In Interactif Visuel Systeme 62
Essilor Acquires 80% Stake In X-Cel Optical 63
Essilor International Acquires Carskadden Optical, Ophthalmic Lab 64
Essilor International Acquires Hirsch Optical, Ophthalmic Lab 65
Essilor Acquires Balester Optical Company 66
Essilor Acquires Majority Stake In Jiangsu Youli Optics 67
Essilor Acquires Majority Stake In Reize Optik 68
Essilor Acquires Majority Stake In Jiangsu Seeworld Optical 69
Satisloh Holding Acquires Majority Stake In CM Equipamentos Opticos 70
Essilor International Acquires 65% Stake In VST Lab 71
Essilor International Acquires Majority Stake In Opti Express 72
Essilor International Acquires 65% Stake In Optiben 73
Essilor International Acquires Professional Ophthalmic Labs 74
Essilor Acquires Majority Stake In CSC Labs 75
Essilor International Compagnie Generale d’Optique SA – Key Competitors 76
Essilor International Compagnie Generale d’Optique SA – Key Employees 77
Essilor International Compagnie Generale d’Optique SA – Locations And Subsidiaries 78
Head Office 78
Other Locations & Subsidiaries 78
Joint Venture 84
Recent Developments 85
Financial Announcements 85
Jul 26, 2018: Essilor: First-Half 2018 results strong second quarter delivering on the growth strategy 85
Mar 01, 2018: Essilor: Solid 2017 earnings Strong fourth quarter 86
Oct 24, 2017: Essilor: Nine-month consolidated revenue up 6.6% in constant currency 87
Oct 24, 2017: Essilor International: Third-Quarter 2017 Report 89
Jul 28, 2017: Essilor International: Resilient First Half 91
Apr 25, 2017: Essilor International: Revenue increases by 10% Q1 in line with planned 2017 growth trajectory 95
Feb 17, 2017: Essilor International Reports 2016 Financial Results 98
Corporate Communications 104
Apr 24, 2018: Essilor announces changes in Board of Directors 104
Feb 07, 2018: Changes to Essilor International (Compagnie Generale D’Optique) Board of Directors 105
Oct 17, 2017: Laura Viscovich appointed Vice President Corporate Communications at Essilor 106
Oct 10, 2017: Essilor Wins A Silmo d’Or Award For Its Varilux X Series 107
Oct 09, 2017: Hilary Halper appointed CFO at Essilor 108
Aug 02, 2017: Essilor wins Sustainable Business Award for its commitment to the United Nation’s Sustainable Development Goals 109
Legal and Regulatory 110
Jul 26, 2018: Proposed combination between Essilor and Luxottica approved in China 110
Mar 01, 2018: Proposed combination between Essilor and Luxotticareceives clearance from US Federal Trade Commission without conditions 111
Mar 01, 2018: Proposed combination between Essilor and Luxottica approved without conditions by the European Commission 112
Jul 24, 2017: Antitrust process update for the proposed combination between Essilor and Luxottica 113
Other Significant Developments 114
May 29, 2018: Essilor partners with the Government of Odisha to launch livelihood building programme, Eye Mitra 114
Apr 16, 2018: Essilor to put proven expertise of vision care capacity-building at the service of the Commonwealth 115
Mar 01, 2018: Essilor to allocate exceptional French tax refund to the Group’s initiatives to eradicate poor vision 116
Sep 26, 2017: Further progress in the proposed combination between Essilor and Luxottica 117
Sep 08, 2017: Essilor is Gold Sponsor of the 2 nd World Congress of Optometry 118
Appendix 119
Methodology 119
About GlobalData 119
Contact Us 119
Disclaimer 119

List of Tables
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Key Facts, 2017 2
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Essilor International Compagnie Generale d'Optique SA, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Essilor International Compagnie Generale d'Optique SA, Deals By Market, 2012 to YTD 2018 11
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Fyidoctors Enters Into Licensing Agreement With Vision Source 17
Safilo Enters Into Licensing Agreement With Essilor 18
Essilor International Enters Into Licensing Agreement With High Performance Optics For Blue Light Filtering Spectacle Lens Technology 19
Coastal Contacts Enters Into Distribution Agreement With Oakley 20
Essilor International Enters Into Distribution Agreement With Lenstech Optical Lab 21
Coastal Contacts Completes Public Offering Of Shares For US$20 Million 22
Essilor International Raises USD328.4 Million in Public Offering of Notes Due 2017 24
Essilor International Raises USD411 Million in Public Offering of 2.375% Notes Due 2024 25
Essilor Prices Public Offering Of Bonds Due 2021 For US$687 Million 26
Essilor International Completes Private Placement Of Notes For US$300 Million 27
Essilor to Acquire Luxottica for USD58.6 Billion 28
Essilor of America Acquires Vision Source from Brazos Private Equity 30
Essilor India to Acquire 36.47% Stake in GKB Vision for USD3.6 Million 31
Essilor Acquires QC Optical 32
Essilor Acquires Majority Stake in Grand Vision 33
Essilor Acquires iCoat, Prescription Lab And Coating Specialist 34
Essilor International Completes Acquisition Of Coastal Contacts For US$387.5 Million 35
Essilor International Completes Acquisition Of Transitions Optical And Intercast Europe From PPG Industries For Up To US$1.73 Billion 37
GetLenses Acquires Vision Direct And Lensbase 39
Essilor Completes Acquisition Of Costa, Manufacturer Of Ophthalmic Lenses, For US$270 Million 40
FGX International Acquires Suntech Optics, Provider Of Eyewear 42
Essilor Acquires VIP Optical Labs 43
Essilor International Acquires Katz & Klein, Optical Lab 44
Essilor International Acquires Majority Stake In Technologies Humanware 45
Essilor International Acquires 50% Stake In Polycore Optical 46
Essilor International Acquires Majority Stake In Classic Optical Lab 47
Essilor International Acquires Majority Stake In e.magine optical 48
Essilor International Acquires Majority Stake In PSA Nilo 49
Essilor International Acquires Majority Stake In Prodigy Optical 50
Essilor Acquires Majority Stake In Onbitt 51
Essilor Acquires Majority Stake In Optiminas 52
Essilor Acquires Majority Stake In Shih Heng, Distributor Of Lens 53
Essilor Acquires Majority Stake In Spherical Optics 54
Essilor International Acquires Majority Stake In Deepak Optic 55
Essilor International Completes Acquisition Of Majority Stake In Isbir Optic 56
Essilor Acquires Majority Stake In EyeBuyDirect.com 57
Essilor International Completes Acquisition Of 51% Stake In Servi Optica 58
Essilor International Completes Acquisition Of Majority Stake In Labs SIVO 59
Essilor Completes Acquisition Of Movisia, Distributor Of Lenses 60
Essilor Acquires Majority Stake In Shanghai Tianhong Optical 61
Essilor Acquires 68.3% Stake In Interactif Visuel Systeme 62
Essilor Acquires 80% Stake In X-Cel Optical 63
Essilor International Acquires Carskadden Optical, Ophthalmic Lab 64
Essilor International Acquires Hirsch Optical, Ophthalmic Lab 65
Essilor Acquires Balester Optical Company 66
Essilor Acquires Majority Stake In Jiangsu Youli Optics 67
Essilor Acquires Majority Stake In Reize Optik 68
Essilor Acquires Majority Stake In Jiangsu Seeworld Optical 69
Satisloh Holding Acquires Majority Stake In CM Equipamentos Opticos 70
Essilor International Acquires 65% Stake In VST Lab 71
Essilor International Acquires Majority Stake In Opti Express 72
Essilor International Acquires 65% Stake In Optiben 73
Essilor International Acquires Professional Ophthalmic Labs 74
Essilor Acquires Majority Stake In CSC Labs 75
Essilor International Compagnie Generale d'Optique SA, Key Competitors 76
Essilor International Compagnie Generale d'Optique SA, Key Employees 77
Essilor International Compagnie Generale d'Optique SA, Subsidiaries 78
Essilor International Compagnie Generale d'Optique SA, Joint Venture 84

List of Figures
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 9
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Essilor International Compagnie Generale d'Optique SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 11

★海外企業調査レポート[Essilor International Compagnie Generale d’Optique SA (EI)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • PJSC Detsky Mir (DSKY)：企業の財務・戦略的SWOT分析
    PJSC Detsky Mir (DSKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Abcodia Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Abcodia Ltd (Abcodia) is a clinical stage company that offers commercial development of novel, scientifically validated tests for the early detection of cancer. The company offers Roca Test, a blood test for early ovarian cancer detection. It validates and discovers biomarkers for early diag …
  • The Shoko Chukin Bank, Ltd.：企業の戦略・SWOT・財務情報
    The Shoko Chukin Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Shoko Chukin Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • GenMark Diagnostics Inc (GNMK)：企業の財務・戦略的SWOT分析
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company offers products such as XT-8 systems and ePlex systems. It offers pipeline products include eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test, …
  • Koss Corp (KOSS)：企業の財務・戦略的SWOT分析
    Summary Koss Corp (Koss) operates as an electronic equipment company that designs, manufactures and markets stereo headphones and other related accessory products. The company provides products such as full size headphones, earbuds and in-ear headphones, ear clip headphones, on-ear headphones, in-li …
  • Al Ain Ahlia Insurance Company PSC：企業の戦略・SWOT・財務分析
    Al Ain Ahlia Insurance Company PSC - Strategy, SWOT and Corporate Finance Report Summary Al Ain Ahlia Insurance Company PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Acorda Therapeutics Inc (ACOR)：製薬・医療：M&Aディール及び事業提携情報
    Summary Acorda Therapeutics Inc (Acorda) is a biopharmaceutical company that discovers, develops, and commercializes therapies for treating patients with neurological disorders. Its portfolio encomppases marketed products for the treatment of multiple sclerosis (MS); and for the management of spasti …
  • Archroma Pakistan Ltd. (ARPL)：企業の財務・戦略的SWOT分析
    Archroma Pakistan Ltd. (ARPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Active Motif Inc：医療機器：M&Aディール及び事業提携情報
    Summary Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products include extracts, antibodies, reporter assays, fluorescent dyes, kits, cell, acid, and tissue extracts, molecules and recombinant proteins, among others. It of …
  • CLP Holdings Ltd (00002)：電力：M&Aディール及び事業提携情報
    Summary CLP Holdings Ltd (CLP) is an investor and operator in the energy sector of Asia Pacific region. The company invests in power generation, transmission and distribution, and electricity and gas retail activities. Its portfolio includes equity generating and purchase capacities. CLP’s generatio …
  • African Development Bank Group：電力：M&Aディール及び事業提携情報
    Summary African Development Bank Group (AfDB) is a development finance institution. It promotes social and economic development by providing loans, grants, guarantees, equity investments and technical assistance in its regional member countries. The constituent institutions of the bank include The A …
  • Bilfinger SE (GBF)：石油・ガス：M&Aディール及び事業提携情報
    Summary Bilfinger SE (Bilfinger) is a provider of industrial engineering services. It offers a wide range of services from consulting, construction, manufacturing, plant expansion to maintenance and project management services across diverse end markets. The company’s major service offerings include …
  • Uflex Limited：企業の戦略・SWOT・財務情報
    Uflex Limited - Strategy, SWOT and Corporate Finance Report Summary Uflex Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Getty Images Inc：企業の戦略的SWOT分析
    Getty Images Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • STMicroelectronics N.V.：企業の戦略・SWOT・財務分析
    STMicroelectronics N.V. - Strategy, SWOT and Corporate Finance Report Summary STMicroelectronics N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Alta Mesa Resources Inc：企業の戦略的SWOT分析
    Alta Mesa Resources Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Genomic Health Inc (GHDX)-医療機器分野：企業M&A・提携分析
    Summary Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer …
  • Kraton Corp (KRA)：企業の財務・戦略的SWOT分析
    Summary Kraton Corp (Kraton) is a chemical company that develops, manufactures and markets biobased chemicals and specialty polymers. The company offers products such as adhesives and sealants, coatings, paving and roofing chemicals, compounding solutions, oil gels, automotive chemicals, fuel additi …
  • NaviNet Inc：企業の戦略的SWOT分析
    NaviNet Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Rigel Pharmaceuticals Inc (RIGL)：製薬・医療：M&Aディール及び事業提携情報
    Summary Rigel Pharmaceuticals Inc. (Rigel) is a biotechnology company that discovers and develops innovative small-molecule drugs for patients with immune disorders, hematological disorders, cancer and rare diseases. Its research activities focus on signaling pathways that are critical to disease me …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆